Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2021

Commitments And Contingencies Disclosure [Abstract]

Remaining Purchase Requirements

In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the nine months ended September 30, 2021. The remaining purchase commitments as of September 30, 2021 and March 31, 2021 (pre-amendment) were as follows:

	September 30, 2021		March 31, 2021
2021	€	0.8 million	€	7.0 million
2022	€	5.4 million	€	8.5 million
2023	€	8.8 million	€	10.9 million
2024	€	14.6 million	€	14.6 million
2025	€	15.5 million	€	15.5 million
2026	€	19.4 million	€	19.4 million
2027	€	9.2 million	€		—

Summary of Lease Information

Lease information is as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Operating lease costs	$	323	$	350	$	1,008	$	1,053
Variable lease costs		128		116		359		296
Cash paid		451		466		1,367		1,349

Schedule of Lease Term and Discount Rate

	September 30, 2021			December 31, 2020
Weighted average remaining lease term (in years)		2.0			1.9
Weighted average discount rate		7.3	%		7.5	%

Schedule of Future Minimum Office And Vehicle Lease Payments

Future minimum office and vehicle lease payments as of September 30, 2021 and December 31, 2020, are as follows (in thousands):

	September 30, 2021		December 31, 2020
2021	$	354	$	1,494
2022		1,302		1,239
2023		266		88
2024		178		—
2025		119		—
Total	$	2,219	$	2,821